Parental type 2 diabetes in patients with non-affective psychosis

Brian J Miller, David R. Goldsmith, Nina Paletta, Joyce Wong, Prianka Kandhal, Carmen Black, Mark Hyman Rapaport, Peter F Buckley

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective People with schizophrenia have an increased risk of diabetes that may be independent of antipsychotics. Previous studies have explored the prevalence of a family history of type 2 diabetes (DM2) in schizophrenia. We hypothesized that parental DM2 is increased in probands with non-affective psychosis (NAP) compared to controls, and parental DM2 predicts comorbid diabetes in NAP, after controlling for potential confounders. Method N = 217 patients with NAP and N = 67 controls were interviewed for a history of parental DM2. NAP was investigated as a predictor of parental DM2 in binary logistic regression models, controlling for age, sex, race, smoking, body mass index, socioeconomic status, and parental psychiatric history. Results There was an increased prevalence of DM2 in the mother (30.0% vs 13.8%, p = 0.013) and in either the mother or father (44.5% vs 24.6%, p = 0.006) in patients with NAP versus controls. After accounting for potential confounders, NAP was associated with significant increased odds of parental DM2 (OR = 2.80, 95% CI 1.08–7.23, p = 0.034). Parental DM2 was also associated with increased odds of comorbid DM2 in NAP (OR = 3.67, 95% CI 1.58–8.56, p = 0.003). Conclusions We replicated an association of an increased prevalence of parental DM2 in patients with NAP. Parental DM2 was also an independent predictor of comorbid DM2 in these patients. These associations may be due to shared environmental or genetic risk factors, or gene by environment interactions. Given risks of incident diabetes with antipsychotic treatment, screening for parental DM2 status is germane to the clinical care of patients with NAP.

Original languageEnglish (US)
Pages (from-to)223-225
Number of pages3
JournalSchizophrenia Research
Volume175
Issue number1-3
DOIs
StatePublished - Aug 1 2016

Fingerprint

Psychotic Disorders
Type 2 Diabetes Mellitus
Antipsychotic Agents
Schizophrenia
Logistic Models
Mothers
Gene-Environment Interaction
Social Class
Fathers
Psychiatry
Patient Care
Body Mass Index
Smoking

Keywords

  • Diabetes
  • Epidemiology
  • Family history
  • Non-affective psychosis
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Miller, B. J., Goldsmith, D. R., Paletta, N., Wong, J., Kandhal, P., Black, C., ... Buckley, P. F. (2016). Parental type 2 diabetes in patients with non-affective psychosis. Schizophrenia Research, 175(1-3), 223-225. https://doi.org/10.1016/j.schres.2016.04.035

Parental type 2 diabetes in patients with non-affective psychosis. / Miller, Brian J; Goldsmith, David R.; Paletta, Nina; Wong, Joyce; Kandhal, Prianka; Black, Carmen; Rapaport, Mark Hyman; Buckley, Peter F.

In: Schizophrenia Research, Vol. 175, No. 1-3, 01.08.2016, p. 223-225.

Research output: Contribution to journalArticle

Miller, BJ, Goldsmith, DR, Paletta, N, Wong, J, Kandhal, P, Black, C, Rapaport, MH & Buckley, PF 2016, 'Parental type 2 diabetes in patients with non-affective psychosis', Schizophrenia Research, vol. 175, no. 1-3, pp. 223-225. https://doi.org/10.1016/j.schres.2016.04.035
Miller BJ, Goldsmith DR, Paletta N, Wong J, Kandhal P, Black C et al. Parental type 2 diabetes in patients with non-affective psychosis. Schizophrenia Research. 2016 Aug 1;175(1-3):223-225. https://doi.org/10.1016/j.schres.2016.04.035
Miller, Brian J ; Goldsmith, David R. ; Paletta, Nina ; Wong, Joyce ; Kandhal, Prianka ; Black, Carmen ; Rapaport, Mark Hyman ; Buckley, Peter F. / Parental type 2 diabetes in patients with non-affective psychosis. In: Schizophrenia Research. 2016 ; Vol. 175, No. 1-3. pp. 223-225.
@article{c2f45db927634f22b63f0cd027b6fd8b,
title = "Parental type 2 diabetes in patients with non-affective psychosis",
abstract = "Objective People with schizophrenia have an increased risk of diabetes that may be independent of antipsychotics. Previous studies have explored the prevalence of a family history of type 2 diabetes (DM2) in schizophrenia. We hypothesized that parental DM2 is increased in probands with non-affective psychosis (NAP) compared to controls, and parental DM2 predicts comorbid diabetes in NAP, after controlling for potential confounders. Method N = 217 patients with NAP and N = 67 controls were interviewed for a history of parental DM2. NAP was investigated as a predictor of parental DM2 in binary logistic regression models, controlling for age, sex, race, smoking, body mass index, socioeconomic status, and parental psychiatric history. Results There was an increased prevalence of DM2 in the mother (30.0{\%} vs 13.8{\%}, p = 0.013) and in either the mother or father (44.5{\%} vs 24.6{\%}, p = 0.006) in patients with NAP versus controls. After accounting for potential confounders, NAP was associated with significant increased odds of parental DM2 (OR = 2.80, 95{\%} CI 1.08–7.23, p = 0.034). Parental DM2 was also associated with increased odds of comorbid DM2 in NAP (OR = 3.67, 95{\%} CI 1.58–8.56, p = 0.003). Conclusions We replicated an association of an increased prevalence of parental DM2 in patients with NAP. Parental DM2 was also an independent predictor of comorbid DM2 in these patients. These associations may be due to shared environmental or genetic risk factors, or gene by environment interactions. Given risks of incident diabetes with antipsychotic treatment, screening for parental DM2 status is germane to the clinical care of patients with NAP.",
keywords = "Diabetes, Epidemiology, Family history, Non-affective psychosis, Schizophrenia",
author = "Miller, {Brian J} and Goldsmith, {David R.} and Nina Paletta and Joyce Wong and Prianka Kandhal and Carmen Black and Rapaport, {Mark Hyman} and Buckley, {Peter F}",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/j.schres.2016.04.035",
language = "English (US)",
volume = "175",
pages = "223--225",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Parental type 2 diabetes in patients with non-affective psychosis

AU - Miller, Brian J

AU - Goldsmith, David R.

AU - Paletta, Nina

AU - Wong, Joyce

AU - Kandhal, Prianka

AU - Black, Carmen

AU - Rapaport, Mark Hyman

AU - Buckley, Peter F

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Objective People with schizophrenia have an increased risk of diabetes that may be independent of antipsychotics. Previous studies have explored the prevalence of a family history of type 2 diabetes (DM2) in schizophrenia. We hypothesized that parental DM2 is increased in probands with non-affective psychosis (NAP) compared to controls, and parental DM2 predicts comorbid diabetes in NAP, after controlling for potential confounders. Method N = 217 patients with NAP and N = 67 controls were interviewed for a history of parental DM2. NAP was investigated as a predictor of parental DM2 in binary logistic regression models, controlling for age, sex, race, smoking, body mass index, socioeconomic status, and parental psychiatric history. Results There was an increased prevalence of DM2 in the mother (30.0% vs 13.8%, p = 0.013) and in either the mother or father (44.5% vs 24.6%, p = 0.006) in patients with NAP versus controls. After accounting for potential confounders, NAP was associated with significant increased odds of parental DM2 (OR = 2.80, 95% CI 1.08–7.23, p = 0.034). Parental DM2 was also associated with increased odds of comorbid DM2 in NAP (OR = 3.67, 95% CI 1.58–8.56, p = 0.003). Conclusions We replicated an association of an increased prevalence of parental DM2 in patients with NAP. Parental DM2 was also an independent predictor of comorbid DM2 in these patients. These associations may be due to shared environmental or genetic risk factors, or gene by environment interactions. Given risks of incident diabetes with antipsychotic treatment, screening for parental DM2 status is germane to the clinical care of patients with NAP.

AB - Objective People with schizophrenia have an increased risk of diabetes that may be independent of antipsychotics. Previous studies have explored the prevalence of a family history of type 2 diabetes (DM2) in schizophrenia. We hypothesized that parental DM2 is increased in probands with non-affective psychosis (NAP) compared to controls, and parental DM2 predicts comorbid diabetes in NAP, after controlling for potential confounders. Method N = 217 patients with NAP and N = 67 controls were interviewed for a history of parental DM2. NAP was investigated as a predictor of parental DM2 in binary logistic regression models, controlling for age, sex, race, smoking, body mass index, socioeconomic status, and parental psychiatric history. Results There was an increased prevalence of DM2 in the mother (30.0% vs 13.8%, p = 0.013) and in either the mother or father (44.5% vs 24.6%, p = 0.006) in patients with NAP versus controls. After accounting for potential confounders, NAP was associated with significant increased odds of parental DM2 (OR = 2.80, 95% CI 1.08–7.23, p = 0.034). Parental DM2 was also associated with increased odds of comorbid DM2 in NAP (OR = 3.67, 95% CI 1.58–8.56, p = 0.003). Conclusions We replicated an association of an increased prevalence of parental DM2 in patients with NAP. Parental DM2 was also an independent predictor of comorbid DM2 in these patients. These associations may be due to shared environmental or genetic risk factors, or gene by environment interactions. Given risks of incident diabetes with antipsychotic treatment, screening for parental DM2 status is germane to the clinical care of patients with NAP.

KW - Diabetes

KW - Epidemiology

KW - Family history

KW - Non-affective psychosis

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84964725766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964725766&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2016.04.035

DO - 10.1016/j.schres.2016.04.035

M3 - Article

VL - 175

SP - 223

EP - 225

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 1-3

ER -